title: Editorial Commentary: Considerations of Favipiravir as a Medical Countermeasure in Future Randomized Controlled Trials Against Ebola Virus Disease.
authors.affiliation: Department of Pathology and Laboratory Medicine.|Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia.
authors.forename: Colleen S
authors.initials: CS
authors.lastname: Kraft
mesh_terms: D000577:Amides; D004196:Disease Outbreaks; D029043:Ebolavirus; D019142:Hemorrhagic Fever, Ebola; D006801:Humans; D011719:Pyrazines; D016032:Randomized Controlled Trials as Topic; D012807:Sierra Leone
chemical_list: D000577:Amides; D011719:Pyrazines; C462182:favipiravir
keywords: Ebola virus disease; Sierra Leone; clinical trials; favipiravir; treatment